Stock 000411 ZHEJIANG INT'L GROUP CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Zhejiang Int'l Group Co.,Ltd. Stock

Equities

000411

CNE0000008D9

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-04-25 EDT 		5-day change 1st Jan Change
10.71 CNY +0.09% Intraday chart for Zhejiang Int'l Group Co.,Ltd. +4.39% -4.46%
04-26 Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-19 Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Financials

Sales 2022 30.62B 4.23B 5.78B Sales 2023 32.05B 4.42B 6.05B Capitalization 5.86B 808M 1.1B
Net income 2022 212M 29.26M 40M Net income 2023 489M 67.49M 92.26M EV / Sales 2022 0.23 x
Net Debt 2022 1.11B 154M 210M Net Debt 2023 936M 129M 177M EV / Sales 2023 0.21 x
P/E ratio 2022
17.8 x
P/E ratio 2023
10.9 x
Employees 2,781
Yield 2022
1.09%
Yield 2023
-
Free-Float 24.09%
More Fundamentals * Assessed data

Chart Zhejiang Int'l Group Co.,Ltd.

Dynamic Chart

Latest news about Zhejiang Int'l Group Co.,Ltd.

Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Zhejiang Int'l Group Co.,Ltd. agreed to acquire 51% stake in Hangzhou Baishan Medical Equipment Co., Ltd. from Shanghai Youjiang Enterprise Development Center (Limited Partnership), Shanghai Tuyu Enterprise Development Center (Limited Partnership), Yun Naiyi and Huang Haihua for CNY 100 million. CI
Zhejiang International to Buy Out Local Pharma Firm in 1.2 Billion Yuan Share Transfer Deal MT
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Zhejiang Int'l Group Co.,Ltd. announced that it has received CNY 399.999996 million in funding from Zhejiang CONBA Pharmaceutical Co.,Ltd. CI
Zhejiang International Secures Nod to Sell 400 Million Yuan of Shares MT
Zhejiang Int'l Group Co.,Ltd. completed the acquisition of remaining 50% stake in Zhejiang Int'l Medicine Co., Ltd. from Zhejiang Huachen Investment Development Co. Ltd. and Zhejiang International Business Group Co.,Ltd. CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Zhejiang Int'l Group Co.,Ltd. announces decision of Shareholder/Board on the transaction CI
Zhejiang Int'l Group Co.,Ltd. announced that it expects to receive CNY 400 million in funding CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
More news

Quotes and Performance

1 day+0.09%
1 week+4.39%
Current month+0.47%
1 month+2.98%
3 months+0.37%
6 months-7.11%
Current year-4.46%
More quotes

Highs and lows

1 week
10.22
Extreme 10.22
10.76
1 month
9.69
Extreme 9.69
10.85
Current year
8.32
Extreme 8.32
11.73
1 year
8.32
Extreme 8.32
15.80
3 years
8.32
Extreme 8.32
16.89
5 years
8.32
Extreme 8.32
26.33
10 years
8.32
Extreme 8.32
36.58
More quotes

Managers and Directors - Zhejiang Int'l Group Co.,Ltd.

Managers TitleAgeSince
Yang Wang CEO
 Chief Executive Officer 43 22-07-05
Xu Jie Ying CHM
 Chairman 51 18-01-24
Rong Fu Fei BRD
 Director/Board Member 39 18-01-18
Members of the board TitleAgeSince
Xu Jie Ying CHM
 Chairman 51 18-01-24
Zheng Wang BRD
 Director/Board Member 49 10-08-25
Yang Wang CEO
 Chief Executive Officer 43 22-07-05
More insiders

Quotes

Date Price Change Volume
24-04-26 10.71 +0.09% 4,522,233
24-04-25 10.7 +1.81% 4,455,106
24-04-24 10.51 +1.15% 3,314,766
24-04-23 10.39 +1.17% 3,978,526
24-04-22 10.27 +0.10% 4,981,202

End-of-day quote Shenzhen S.E., April 25, 2024

More quotes

Company Profile

ZHEJIANG INT'L GROUP CO., LTD. is a China-based company principally engaged in the wholesale and retail of pharmaceuticals and medical equipment. The Company purchases products from pharmaceutical manufacturers or suppliers, then wholesales them to distributors, medical institutions and pharmacies, or sells them directly to consumers through retail terminals. The Company conducts its businesses in Mainland China.
Sector
Pharmaceuticals
Calendar
2024-05-14 - Annual General Meeting
More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
ZHEJIANG INT'L GROUP CO.,LTD. Stock Zhejiang Int'l Group Co.,Ltd.
-4.46% 772M
MCKESSON CORPORATION Stock McKesson Corporation
+17.35% 71.39B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+2.39% 25.1B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+5.38% 8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+6.69% 8.19B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.96% 7.91B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+0.49% 4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+17.12% 4.31B
GALENICA AG Stock Galenica AG
-2.61% 3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+22.08% 3.64B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 000411 Stock